AU4961499A - 5-HT1f agonists - Google Patents

5-HT1f agonists

Info

Publication number
AU4961499A
AU4961499A AU49614/99A AU4961499A AU4961499A AU 4961499 A AU4961499 A AU 4961499A AU 49614/99 A AU49614/99 A AU 49614/99A AU 4961499 A AU4961499 A AU 4961499A AU 4961499 A AU4961499 A AU 4961499A
Authority
AU
Australia
Prior art keywords
ht1f agonists
ht1f
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49614/99A
Inventor
Joseph Herman Krushinski Jr.
Vincent Patrick Rocco
John Mehnert Schaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU4961499A publication Critical patent/AU4961499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU49614/99A 1998-06-26 1999-06-24 5-HT1f agonists Abandoned AU4961499A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9087298P 1998-06-26 1998-06-26
US60090872 1998-06-26
US9495798P 1998-07-31 1998-07-31
US60094957 1998-07-31
PCT/US1999/014502 WO2000000490A2 (en) 1998-06-26 1999-06-24 5-ht1f agonists

Publications (1)

Publication Number Publication Date
AU4961499A true AU4961499A (en) 2000-01-17

Family

ID=26782729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49614/99A Abandoned AU4961499A (en) 1998-06-26 1999-06-24 5-HT1f agonists

Country Status (2)

Country Link
AU (1) AU4961499A (en)
WO (1) WO2000000490A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211594B2 (en) 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
EP1361225B1 (en) 2001-01-22 2007-11-07 Sankyo Company, Limited Compounds substituted with bicyclic amino groups
ME00549B (en) * 2001-01-29 2011-10-10 Serono Lab Use of il-18 inhibitors for the treatment and/or prevention of heart disease
CN1300116C (en) 2001-04-16 2007-02-14 卫材株式会社 Novel 1H-indazole compound
TWI263497B (en) 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
CN1777584A (en) 2003-04-18 2006-05-24 伊莱利利公司 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists
UA82711C2 (en) 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
JP2007516266A (en) 2003-12-17 2007-06-21 イーライ リリー アンド カンパニー Substituted (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl compounds as 5-HT1F agonists
WO2011123654A1 (en) 2010-04-02 2011-10-06 Colucid Pharmaceuticals, Inc. Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
CN103044316A (en) * 2013-01-23 2013-04-17 石家庄学院 Method for preparing 1,4-dihydropyridine by using imidazole ionic liquid as catalyst
TWI829107B (en) 2019-07-09 2024-01-11 美商美國禮來大藥廠 Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds
GB9226532D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
CN1121348A (en) * 1993-04-22 1996-04-24 辉瑞研究及发展公司 Indole derivatives as 5-H1-like agonists for use in migraine
AU694226B2 (en) * 1994-05-19 1998-07-16 Merck Sharp & Dohme Limited Piperazine, piperidine and tetrahydropyridine derivatives ofindol-3-ylalkyl as 5-HT1D-alpha agonists
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
CZ288897A3 (en) * 1995-03-20 1998-02-18 Eli Lilly And Company In position 5-substituted 3-(1,2,3,6-tetrahydropyridin-4-yl)indole and 3-(piperidin-4-yl)indole, as well as pharmaceutical composition containing thereof

Also Published As

Publication number Publication date
WO2000000490A3 (en) 2003-04-17
WO2000000490A2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
AU5203999A (en) Beta3-adrenergic receptor agonists
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU7128798A (en) Substituted heteroaromatic 5-ht1f agonists
AU4961499A (en) 5-HT1f agonists
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
HUP0004317A3 (en) 5-ht1f agonists
AU5688499A (en) Non-knotting line
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU8363398A (en) Capotasto
IL144355A0 (en) 5-ht1f agonists
AU5112699A (en) 5-HT1f antagonists
AU2609599A (en) Sensor-coupling
AU4511499A (en) Substituted cyclooctadepsipeptides
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU5223199A (en) Bathtub-bathseat
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU2840799A (en) 1-phosphanorbornadienes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase